Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery

Carbohydrate Polymers

Volumn 149, Issue , 2016, Pages 224-230

  Zhang, Ping ^a   Liu, Xin ^a   Hu, Wenjing ^b   Bai, Yan ^a   Zhang, Liangke ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b People's Hospital of Shapingba District   (China)

Author keywords

Chitosan nanoparticles; Naringenin; Ocular drug delivery

Indexed keywords

BIOCHEMISTRY; CHITIN; CHITOSAN; CYCLODEXTRINS; FLAVONOIDS; GELATION; MICROCRYSTALS; ORGANIC COMPOUNDS; SUSPENSIONS (FLUIDS);

CHITOSAN NANOPARTICLES; IONIC GELATIONS; NARINGENIN; OCULAR DRUG DELIVERY; OPHTHALMIC DELIVERY; POORLY SOLUBLE DRUGS; RESIDENCE TIME; SUSTAINED RELEASE;

NANOPARTICLES;

BETA CYCLODEXTRIN DERIVATIVE; CHITOSAN; DRUG CARRIER; FLAVANONE DERIVATIVE; NANOPARTICLE; NARINGENIN; SBE4-BETA-CYCLODEXTRIN;

ANIMAL; CHEMISTRY; DRUG RELEASE; FEMALE; LEPORIDAE; MACULAR DEGENERATION; MALE; PARTICLE SIZE; SOLUBILITY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; BETA-CYCLODEXTRINS; CHITOSAN; DRUG CARRIERS; DRUG LIBERATION; FEMALE; FLAVANONES; MACULAR DEGENERATION; MALE; NANOPARTICLES; PARTICLE SIZE; RABBITS; SOLUBILITY;

EID: 84966396993     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2016.04.115     Document Type: Article

References (32)

1. S.B. Bloch, M. Larsen, and I.C. Munch Incidence of legal blindness from age-related macular degeneration in denmark: year 2000-2010 American Journal of Ophthalmology 153 2 2012 209 213 [e202]
2. J.P. Campbell, and N.M. Bressler Impact of availability of anti-vascular endothelial growth factor therapy on visual impairment and blindness due to neovascular age-related macular degeneration Archives of Ophthalmology 130 6 2012 794 795
3. A.M. De Campos, A. Sánchez, and M.A.J. Alonso Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A International Journal of Pharmaceutics 224 1-2 2001 159 168
4. N. Devasari, C.P. Dora, C. Singh, S.R. Paidi, V. Kumar, M.E. Sobhia, and et al. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: preparation, characterization, in silico, in vitro and in vivo evaluation Carbohydrate Polymers 134 2015 547 556
5. Y. Diebold, and M. Calonge Applications of nanoparticles in ophthalmology Progress in Retinal and Eye Research 29 6 2010 596 609
6. E. Eljarrat-Binstock, F. Orucov, Y. Aldouby, J. Frucht-Pery, and A.J. Domb Charged nanoparticles delivery to the eye using hydrogel iontophoresis Journal of Controlled Release 126 2 2008 156 161
7. G.M. Fernandes-Cunha, D.R. Gouvea, O. Fulgencio Gde, C.M. Rezende, G.R. da Silva, J.M. Bretas, and et al. Development of a method to quantify clindamycin in vitreous humor of rabbits' eyes by UPLC-MS/MS: application to a comparative pharmacokinetic study and in vivo ocular biocompatibility evaluation Journal of Pharmaceutical and Biomedical Analysis 102 2015 346 352
8. R. Gaudana, H.K. Ananthula, A. Parenky, and A.K. Mitra Ocular drug delivery The AAPS Journal 12 3 2010 348 360
9. T. Higuchi, and A.K. Connors Phase-solubility techniques Advances in Analytical Chemistry and Instrumentation 4 1965 117 212
10. J. Ji, X.R. Xu, and G.C.Y. Chiou Effects of naringenin on ocular blood flow and choroidal neovascularization in experimental animals International Journal of Ophthalmology 2 2009 320 323
11. T. Kean, and M. Thanou Biodegradation, biodistribution and toxicity of chitosan Advanced Drug Delivery Reviews 62 1 2010 3 11
12. S.K. Khalil, G.S. El-Feky, S.T. El-Banna, and W.A. Khalil Preparation and evaluation of warfarin-beta-cyclodextrin loaded chitosan nanoparticles for transdermal delivery Carbohydrate Polymers 90 3 2012 1244 1253
13. J. Li, H. Liu, L.L. Liu, C.N. Cai, H.X. Xin, and W. Liu Design and evaluation of a brinzolamide drug-resin in situ thermosensitive gelling system for sustained ophthalmic drug delivery Chemical and Pharmaceutical Bulletin 62 10 2014 1000 1008
14. L.S. Lim, P. Mitchell, J.M. Seddon, F.G. Holz, and T.Y. Wong Age-related macular degeneration The Lancet 379 9827 2012 1728 1738
15. J. Lin, J. Sun, Y. Wang, Y. Ma, W. Chen, Z. Zhang, and et al. Ocular pharmacokinetics of naringenin eye drops following topical administration to rabbits Journal of Ocular Pharmacology and Therapeutics 31 1 2015 51 56
16. J.L. Lin, Y.D. Wang, Y. Ma, C.M. Zhong, M.R. Zhu, W.P. Chen, and et al. Protective effects of naringenin eye drops on N-methyl-N-nitrosourea-induced photoreceptor cell death in rats International Journal of Ophthalmology 7 3 2014 391 396
17. J. Lou, W. Hu, R. Tian, H. Zhang, Y. Jia, J. Zhang, and et al. Optimization and evaluation of a thermoresponsive ophthalmic in situ gel containing curcumin-loaded albumin nanoparticles International Journal of Nanomedicine 9 2014 2517 2525
18. D.R. Luke, K. Tomaszewski, B. Damle, and H.T. Schlamm Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD) Journal of Pharmaceutical Sciences 99 8 2010 3291 3301
19. Y. Luo, and Q. Wang Recent development of chitosan-based polyelectrolyte complexes with natural polysaccharides for drug delivery International Journal of Biological Macromolecules 64 2014 353 367
20. A.A. Mahmoud, G.S. El-Feky, R. Kamel, and G.E. Awad Chitosan/sulfobutylether-beta-cyclodextrin nanoparticles as a potential approach for ocular drug delivery International Journal of Pharmaceutics 413 1-2 2011 229 236
21. S. Majumdar, and R. Srirangam Potential of the bioflavonoids in the prevention/treatment of ocular disorders The Journal of Pharmacy and Pharmacology 62 8 2010 951 965
22. S.K. Motwani, S. Chopra, S. Talegaonkar, K. Kohli, F.J. Ahmad, and R.K. Khar Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation European Journal of Pharmaceutics and Biopharmaceutics 68 3 2008 513 525
23. R.C. Nagarwal, S. Kant, P.N. Singh, P. Maiti, and J.K. Pandit Polymeric nanoparticulate system: a potential approach for ocular drug delivery Journal of Controlled Release 136 1 2009 2 13
24. Y.H. Park, and G.C.Y. Chiou Structure-activity relationship (SAR) between some natural flavonoids and ocular blood flow in the rabbit Journal of Ocular Pharmacology and Therapeutics 20 1 2004 35 42
25. E. Pinho, M. Grootveld, G. Soares, and M. Henriques Cyclodextrins as encapsulation agents for plant bioactive compounds Carbohydrate Polymers 101 2014 121 135
26. V. Pittala, L. Salerno, G. Romeo, M.A. Siracusa, M.N. Modica, G.L. Romano, and et al. Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation European Journal of Pharmacology 752 2015 78 83
27. L. Ren, Y. Zhou, P. Wei, M. Li, and G. Chen Preparation and pharmacokinetic study of aprepitant-sulfobutyl ether-beta-cyclodextrin complex AAPS PharmSciTech 15 1 2014 121 130
28. Y. Shen, W.Y. Zhang, and G.C. Chiou Effect of naringenin on NaIO(3)-induced retinal pigment epithelium degeneration and laser-induced choroidal neovascularization in rats International Journal of Ophthalmology 3 1 2010 5 8
29. A. Trapani, A. Lopedota, M. Franco, N. Cioffi, E. Ieva, M. Garcia-Fuentes, and et al. A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides European Journal of Pharmaceutics and Biopharmaceutics 75 1 2010 26 32
30. C.S. Wu, Y.C. Hsu, H.T. Liao, and Y.X. Cai Antibacterial activity and in vitro evaluation of the biocompatibility of chitosan-based polysaccharide/polyester membranes Carbohydrate Polymers 134 2015 438 447
31. C. Xu, Y. Tang, W. Hu, R. Tian, Y. Jia, P. Deng, and et al. Investigation of inclusion complex of honokiol with sulfobutyl ether-beta-cyclodextrin Carbohydrate Polymers 113 2014 9 15
32. L.J. Yang, S.X. Ma, S.Y. Zhou, W. Chen, M.W. Yuan, Y.Q. Yin, and et al. Preparation and characterization of inclusion complexes of naringenin with beta-cyclodextrin or its derivative Carbohydrate Polymers 98 1 2013 861 869